In line with this observation, we did not observe any adverse effects during the course of treatment and, accordingly, recent studies at low risk of bias did not find an increased risk of infections in patients with RA treated with TNF antagonists42,43. This evidence concerns the gene TNF and rheumatoid arthritis.